Cantel Medical Corporation

Apyx Medical Corporation Appoints Matthew Hill as Chief Financial Officer

Retrieved on: 
Tuesday, November 28, 2023
Biotechnology, Surgery, General Health, Health, Medical Devices, Health Technology, Technology, Other Technology, CFO, Plasma, Cardiac electrophysiology, Accounting, Strata Skin Sciences, Lehigh University, Senior, Marketing, Financial management, Forecasting, Cantel Medical Corporation, Growth, PDSB, EP, Pharmaceutical industry, Nursing, Science

Apyx Medical Corporation (Nasdaq:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced the appointment of Matthew Hill to the position of Chief Financial Officer, effective December 4, 2023.

Key Points: 
  • Apyx Medical Corporation (Nasdaq:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced the appointment of Matthew Hill to the position of Chief Financial Officer, effective December 4, 2023.
  • Mr. Hill succeeds Tara Semb, whose departure was announced by the Company on November 9, 2023.
  • “Matt joins our executive leadership team with over 30 years of financial and operational experience, more than 20 years of which has been in the healthcare industry, where he has served as the Chief Financial Officer of four publicly-traded healthcare companies,” said Charlie Goodwin, President and Chief Executive Officer of Apyx Medical.
  • “I am pleased to join the Company at this exciting time, and look forward to working with Charlie and the rest of the team as we lead Apyx Medical through its next stage of growth and development.”
    Mr. Hill joins Apyx Medical from PDS Biotechnology Corporation (Nasdaq: PDSB; “PDS Biotech”), a clinical-stage immunotherapy company, where he served as Chief Financial Officer, leading all aspects of the company’s budgeting, forecasting, financial management and reporting.

AmeriWater, a Portfolio Company of Edgewater Capital Partners, Appoints Greg Reny as President & CEO

Retrieved on: 
Wednesday, November 29, 2023
Marketing, Kidney, Cantel Medical Corporation, Dialysis, Senior, Fresenius Medical Care, Medtech, Management

Mr. Reny succeeds former CEO, Dennis Mahoney, who will remain on the company's Board of Directors.

Key Points: 
  • Mr. Reny succeeds former CEO, Dennis Mahoney, who will remain on the company's Board of Directors.
  • Mr. Reny is a medical technology executive with 30 years of cross-functional international business leadership experience.
  • He most recently served as Senior Vice President and General Manager of the Renal business unit at STERIS, which was divested by STERIS to Evoqua in 2022.
  • I look forward to connecting with the talented team as we endeavor together towards a very bright and exciting future for the company," said Mr. Reny.

Apyx Medical Corporation to Participate in Upcoming Investor Conferences in November

Retrieved on: 
Tuesday, November 7, 2023
Health, General Health, Plasma, Conference, Sheraton, Piper Sandler Companies, Lotte New York Palace Hotel, Cantel Medical Corporation, Hotel

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, announced today that management will participate in the following upcoming investor conferences:

Key Points: 
  • Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, announced today that management will participate in the following upcoming investor conferences:
    The Stephens Annual Investment Conference at the Nashville Grand Hyatt in Nashville, TN
    Management will participate in a fireside chat on Tuesday, November 14 at 12:00 p.m. Eastern Time.
  • The Craig-Hallum 14th Annual Alpha Select Conference at the Sheraton NY Times Square Hotel in New York, NY
    Management will participate in 1x1 meetings on Thursday, November 16.
  • Audio webcasts of the fireside chat will be provided under the ‘Company Events’ section of the Apyx Medical Corporation investor relations website at https://apyxmedical.com/investor_relations/ .
  • The webcasts will be achieved and available for replay following the conferences.

STERIS Announces Dividend of $0.52 per share

Retrieved on: 
Tuesday, October 31, 2023
Pillar, FDA, Insurance, NYSE, American Bar Association Model Rules of Professional Conduct, Literature, Pressure, IRA, CAMT, Congress, Legislation, Acquisition, Health, TCJA, EPA, Growth, Risk, COVID-19, MLI, Income tax, Marketing, Steris, Annual report, Accounting, STE, Cantel Medical Corporation, Brexit, EU

DUBLIN, IRELAND, Oct. 31, 2023 (GLOBE NEWSWIRE) --  STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.52 per share.

Key Points: 
  • DUBLIN, IRELAND, Oct. 31, 2023 (GLOBE NEWSWIRE) --  STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.52 per share.
  • The dividend is payable on December 21, 2023, to shareholders of record at the close of business on November 21, 2023.
  • STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention.
  • WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare, life sciences and dental products and services around the globe.

The AZEK® Company Announces Peter Clifford to Take on Dual Role as Chief Operations Officer and Chief Financial Officer; Promotes Randy Herth to Chief Accounting Officer and Treasurer

Retrieved on: 
Thursday, September 28, 2023
Architecture, Residential Building & Real Estate, Manufacturing, Construction & Property, Other Manufacturing, Landscape, Information technology, Accounting, Organization, Federal Ministry of Science, Technology and Innovation, Acquisition, General Electric Company, Sri Lanka Army Medical Corps, Cantel Medical Corporation, Growth, Steris, Market for corporate control, NYSE, IDEX Corporation, Management

Mr. Clifford will also continue to serve as the Company’s Senior Vice President & Chief Financial Officer.

Key Points: 
  • Mr. Clifford will also continue to serve as the Company’s Senior Vice President & Chief Financial Officer.
  • In this new role, Mr. Clifford will assume operations oversight, while continuing to lead all finance, accounting, investor relations, information technology and corporate development functions.
  • Before joining Cantel Medical Corp., Mr. Clifford served as Chief Financial Officer – Health & Science Technologies & Fluid Metering Technology Divisions of IDEX Corporation.
  • Donnelly & Sons Company and Euramax International, Inc.
    “Randy has been a valued part of our accounting leadership team since joining AZEK in 2022,” said Peter Clifford, AZEK’s Chief Financial Officer.

STERIS Completes the Acquisition of Surgical Instrumentation Assets from BD

Retrieved on: 
Wednesday, August 2, 2023
Pillar, Insurance, Pressure, LLP, American Bar Association Model Rules of Professional Conduct, STE, Marketing, Health care, COVID-19, TCJA, Income tax, Risk, IRA, Sterilization, Accounting, Congress, EPA, Literature, Acquisition, Annual report, Growth, CAMT, Steris, MLI, FDA, BD (company), Health, BDX, NYSE, Legislation, EU, Brexit, Cantel Medical Corporation

DUBLIN, IRELAND, Aug. 02, 2023 (GLOBE NEWSWIRE) --  STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that it has completed the previously announced acquisition of the surgical instrumentation, laparoscopic instrumentation and sterilization container assets from BD (Becton, Dickinson and Company) (NYSE:BDX).

Key Points: 
  • DUBLIN, IRELAND, Aug. 02, 2023 (GLOBE NEWSWIRE) --  STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that it has completed the previously announced acquisition of the surgical instrumentation, laparoscopic instrumentation and sterilization container assets from BD (Becton, Dickinson and Company) (NYSE:BDX).
  • “We welcome these teams to STERIS and look forward to working together to enhance our value to our Customers.”
    Lazard served as financial advisor to STERIS and Thompson Hine LLP served as legal counsel.
  • STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention.
  • WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare, life sciences and dental products and services.

STERIS Raises Dividend to $0.52 per share

Retrieved on: 
Wednesday, July 26, 2023
Pillar, Insurance, Pressure, American Bar Association Model Rules of Professional Conduct, STE, Marketing, COVID-19, TCJA, Income tax, Risk, IRA, Accounting, Congress, EPA, Literature, Acquisition, Annual report, Growth, CAMT, Steris, MLI, FDA, Health, NYSE, Legislation, EU, Brexit, Cantel Medical Corporation

DUBLIN, IRELAND , July 26, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.52 per share.

Key Points: 
  • DUBLIN, IRELAND , July 26, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.52 per share.
  • This represents a $0.05 increase in the dividend and the Company’s 18th consecutive year of dividend growth.
  • The dividend is payable on September 22, 2023, to shareholders of record at the close of business on September 6, 2023.
  • STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention.

DexCare Appoints Robin Borg as Chief People Officer to Cultivate World-Class Talent to Fuel Growth

Retrieved on: 
Tuesday, June 27, 2023
Managed Care, Health Technology, Health, Practice Management, Boston Scientific, Workplace, Robin, Emerge Commerce, Human, Senior Professional Baseball Association, Certification, Galileo Galilei, Acquisition, Professional in Human Resources, Borg, SPHR, Optum, Growth, Cantel Medical Corporation, CPO, St. Jude Medical, Management, Nursing

“Robin has a long track record of cultivating talent to make teams more efficient, empowered and motivated,” said Derek Streat, CEO of DexCare. “We’ve always been focused on creating a purpose-driven culture because we value our talent above all else. The addition of Robin -- and her expertise and relentless passion -- enables DexCare to sustain its growth and build a team that is equipped to meet the mission of improving access to care.”

Key Points: 
  • DexCare , Inc., the leading patient demand and care access platform, has named Robin Borg, SPHR, as chief people officer (CPO).
  • As CPO, Borg strengthens DexCare’s recruiting and talent development process, and will further unify teams across locations.
  • With more than 30 years of experience in human resources, Borg plays an essential role to ensure DexCare attracts and retains top-notch talent to support the company’s continued growth.
  • “Robin has a long track record of cultivating talent to make teams more efficient, empowered and motivated,” said Derek Streat, CEO of DexCare.

Global Laboratory Filtration Market Report 2023: Players Include 3M, Danaher, Sterlitech, Merck and Sartorius - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 14, 2023
Biotechnology, Health, Science, Pharmaceutical, Research, 3M, DNA, Food, Minnesota Golden Gophers men's ice hockey notable players and award winners, Steris, Immobilization, Danaher Corporation, Sterilization, Cantel Medical Corporation, Agilent Technologies, Protein, Sartorius AG, Drug discovery, Growth, Fine chemical

The global laboratory filtration market is expected to grow at 7.5% by 2031.

Key Points: 
  • The global laboratory filtration market is expected to grow at 7.5% by 2031.
  • Technical developments, growing use of filtration technologies in biotechnology and drug discovery and development, clinical laboratories has assisted the laboratory filtration market to achieve impressive growth rate.
  • Growing biopharmaceutical research activities and urge for rapid drug commercialization are the prime drivers of laboratory filtration market.
  • Key players identified for laboratory filtration market include but are not limited to:
    Agilent Technologies Inc., The 3M Company, Danaher Corporation, Sterlitech Corporation, Merck Kgaa, Sartorius Ag, Antylia Scientific, Steris Plc.

STERIS Announces $500 million Share Repurchase Authorization and Declares $0.47 per share Dividend

Retrieved on: 
Wednesday, May 3, 2023
Pressure, STE, Tax Cuts and Jobs Act of 2017, Marketing, COVID-19, TCJA, Risk, Accounting, Share repurchase, Congress, EPA, Literature, Acquisition, Annual report, Tax, Growth, Steris, FDA, Health, NYSE, Legislation, Risk management, EU, Customer, Brexit, Cantel Medical Corporation

The repurchase program may be suspended or discontinued at any time.

Key Points: 
  • The repurchase program may be suspended or discontinued at any time.
  • In addition, the Company will distribute a quarterly interim dividend of $0.47 per share.
  • The dividend is payable on June 28, 2023, to shareholders of record at the close of business on June 14, 2023.
  • STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention.